Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BSD sets sights on US 510(k) for MicroThermX:

This article was originally published in Clinica

Executive Summary

BSD Medical has begun preparations to gain US FDA 510(k) clearance for its MicroThermX 100 system for treating cancer via precision-guided microwave thermal ablation. The Salt Lake City, Utah company, which already sells precision-guided radiofrequency (RF) and microwave systems for use in conjunction with chemotherapy and/or radiotherapy, said that the new product is intended to broadly expand its market by also targeting cancers that can be treated by heat alone. Another of the firm's RF/microwave heating cancer treatment systems, BSD-2000, is pending premarket approval (PMA) clearance in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052741

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel